Metronidazole adverse effects
Pro Research Analysisby 
Searched over 200M research papers
Adverse Effects of Metronidazole: A Comprehensive Overview
Common Adverse Effects: Gastrointestinal Symptoms and Metallic Taste
Metronidazole, a widely used antibiotic, is known for its effectiveness against anaerobic bacteria and protozoal infections. However, it is also associated with several adverse effects. Commonly reported side effects include gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea, as well as a metallic taste in the mouth1 3 4. These symptoms typically appear within the first few days of treatment and often resolve within a few days of onset3.
Neurological Toxicity: Central and Peripheral Nervous System Effects
Metronidazole can cause significant neurological toxicity, affecting both the central and peripheral nervous systems. Symptoms of central nervous system (CNS) toxicity include cerebellar syndrome, encephalopathy, seizures, dysarthria, gait instability, and altered mental status2 7 8. Peripheral nervous system (PNS) toxicity often presents as neuropathy2 8. Risk factors for these neurological adverse events include prolonged use, high cumulative doses, liver disease, chronic kidney disease, and intravenous administration of the drug9.
Rare but Serious Adverse Effects: Neurotoxicity and Encephalopathy
Although rare, metronidazole-induced neurotoxicity can be severe. Cases have been reported where patients developed symptoms such as ataxia, dysarthria, and encephalopathy after prolonged use of the drug7 9 10. MRI findings in these cases often show reversible symmetrical hyperintense lesions on T2/FLAIR of the dentate nuclei, which are highly characteristic of metronidazole-induced encephalopathy8. Early recognition and discontinuation of the drug usually lead to significant improvement in symptoms8 10.
Risk Factors and Patient Demographics
Certain patient demographics and conditions increase the likelihood of experiencing adverse effects from metronidazole. Diabetes, being female, and being under 49 years old are associated with a higher incidence of side effects1. Additionally, patients with liver cirrhosis, chronic kidney disease, and those receiving intravenous administration of metronidazole are at increased risk for neurological adverse events9.
Conclusion
While metronidazole is an effective and widely used antibiotic, it is associated with a range of adverse effects, from common gastrointestinal symptoms to rare but serious neurological toxicity. Awareness of these potential side effects and the associated risk factors is crucial for healthcare providers to manage and mitigate these risks effectively. Early recognition and appropriate management, including discontinuation of the drug when necessary, can significantly improve patient outcomes.
Sources and full results
Most relevant research papers on this topic